Skip to main content
. 2020 Sep 2;12(9):2490. doi: 10.3390/cancers12092490

Table 1.

Number of CTCs isolated for each patient at each access time A, B and C.

Patient Code BC Subtype Access Time Total
A B C
1 TNBC 6 0 0 6
2 TNBC 1 2 1 4
3 TNBC 0 1 3 4
4 TNBC 6 3 3 12
TNBC total 13 6 7 26
6 HER2+ 1 1 1 3
7 Luminal A 1 1 1 3
8 Luminal A 2 3 0 5
9 Luminal A 1 1 1 3
10 Luminal A 1 0 2 3
11 Luminal A 3 0 0 3
12 Luminal A 2 1 0 3
Non-TNBC total 11 7 5 23
Total 24 13 12 49

BC: breast cancer; TNBC: triple-negative BC; HER2: H uman Epidermal Growth Factor Receptor 2.